Post

In persons with HIV and barriers to adhering to antiretroviral therapy, a long-acting injectable treatment (monthly cabotegravir plus rilpivirine) resulted in better virologic control than standard oral ART. Full phase 3 LATITUDE trial results: nej.md/4qFyjMm #MedSky #IDSky